approval
saveIBANDRONATE SODIUM — FDA approval
community read0 votes
Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 244d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 244d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 244d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 244d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 244d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 244d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 244d ago
- approvalIBANDRONATE SODIUM — FDA approvalJul 25, 2025 · 437d ago
same company · ±60 days · 6
- approvalATROPINE SULFATE: ATROPINE SULFATE — FDA approvalFeb 4, 2026
- approvalEfudex: FLUOROURACIL — FDA approvalFeb 5, 2026
- approvalEfudex: FLUOROURACIL — FDA approvalFeb 5, 2026
- approvalDaptomycin Novo: DAPTOMYCIN — FDA approvalJan 26, 2026
- approvalquetiapine fumarate ER: QUETIAPINE FUMARATE — FDA approvalJan 7, 2026
- approvalMaxtrex: METHOTREXATE — FDA approvalMar 13, 2026
comments(0)
5-min edit window · permanent after that